Skip to main content
Albert Kheradpour, MD, Pediatric Hematology & Oncology, San Bernardino, CA

AlbertKheradpourMD

Pediatric Hematology & Oncology San Bernardino, CA

Assistant Professor, Pediatrics, Loma Linda University School of Medicine

Dr. Kheradpour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kheradpour's full profile

Already have an account?

  • Office

    250 E Caroline St
    Ste J
    San Bernardino, CA 92408
    Phone+1 909-558-4800
    Fax+1 909-651-1933

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1991 - 1994
  • Atlantic Health System/Goryeb Children's Hospital
    Atlantic Health System/Goryeb Children's HospitalResidency, Pediatrics, 1989 - 1991
  • Icahn School of Medicine at Mount Sinai (Jersey City)
    Icahn School of Medicine at Mount Sinai (Jersey City)Internship, Pediatrics, 1988 - 1989
  • Tehran University of Medical Sciences School of Medicine
    Tehran University of Medical Sciences School of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2026
  • NJ State Medical License
    NJ State Medical License 1989 - 1999
  • TX State Medical License
    TX State Medical License 1995 - 1999
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Loma Linda University Children’s Hospital Receives $48,000 St. Baldrick’s Foundation Grant to Expand Pediatric Cancer Clinical Trials
    Loma Linda University Children’s Hospital Receives $48,000 St. Baldrick’s Foundation Grant to Expand Pediatric Cancer Clinical TrialsDecember 2nd, 2024